Commentary
Angry at High Drug Prices? A Letter in The Post Is to Blame (sort of)
Commentary
,
May, 2024
Peter Arno,
Kathryn Ardizzone
Commentary
Commentary
,
Mar, 2022
Peter Arno,
Kathryn Ardizzone
Commentary
Commentary
,
Jan, 2022
Peter Arno,
Robert Sachs,
Kathryn Ardizzone
Commentary
March-In Rights Could Ensure Patient Access By Keeping Drug Prices In Check. They're under Attack.
Commentary
,
May, 2021
Peter Arno,
Dana Neacsu,
Kathryn Ardizzone
Results 1 - 4 of 4
